What is Contineum Therapeutics, Inc. Class A Common Stock (CTNM) stock price today?

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) currently trades at $12.82 per share. The stock has a market capitalization of $463.34M and a P/E ratio of —x.

Is CTNM stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Contineum Therapeutics, Inc. Class A Common Stock has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

CTNM

Contineum Therapeutics, Inc. Class A Common Stock

NASDAQ: CTNM · HEALTHCARE · BIOTECHNOLOGY

$12.82

+6.48% today

Updated 2026-04-30

Market cap

$463.34M

P/E ratio

—

P/S ratio

11.15x

EPS (TTM)

$-2.17

Dividend yield

—

52W range

$3 – $16

Volume

0.3M

Market cap

$463.34M

P/E ratio

—

P/S ratio

11.15x

EPS (TTM)

$-2.17

Dividend yield

—

52W range

$3 – $16

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$22.00

+71.61%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-13.08M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$50.00M	$0.00	$0.00	$0.00
Net income	$-24.25M	$22.72M	$-42.26M	$-59.98M	$-15.16M
EPS	—	—	—	—	$-2.17
Free cash flow	$-20.24M	$18.93M	$-33.36M	$-55.54M	$-13.08M
Profit margin	—	45.44%	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CTNM	$463.34M	31	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Contineum Therapeutics, Inc. Class A Common Stock trades at $12.82. Our Smart Value Score of 31/100 indicates the stock is weak.

Frequently asked questions

What is Contineum Therapeutics, Inc. Class A Common Stock's stock price?

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) trades at $12.82.

Is Contineum Therapeutics, Inc. Class A Common Stock overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell).

What is the price target of Contineum Therapeutics, Inc. Class A Common Stock (CTNM)?

The analyst target price is $22.00, representing +71.6% upside from the current price of $12.82.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio11.15x

ROE-26.10%

Beta1.39

50D MA$13.71

200D MA$11.31

Shares out0.03B

Float0.03B

Short ratio—

Avg volume0.3M

Performance

1 week-1.37%

1 month-2.77%

3 months-7.95%

YTD+13.47%

1 year—

3 years—

5 years—

Compare

CTNM vs LLY →CTNM vs JNJ →CTNM vs ABBV →Stock screener →